232,704 Shares in Hims & Hers Health, Inc. (NYSE:HIMS) Acquired by Retirement Systems of Alabama

Retirement Systems of Alabama purchased a new position in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 232,704 shares of the company's stock, valued at approximately $6,876,000. Retirement Systems of Alabama owned about 0.10% of Hims & Hers Health as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of HIMS. Blume Capital Management Inc. increased its stake in Hims & Hers Health by 100.0% during the 4th quarter. Blume Capital Management Inc. now owns 1,200 shares of the company's stock worth $29,000 after buying an additional 600 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in shares of Hims & Hers Health by 4,415.6% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the company's stock worth $36,000 after acquiring an additional 1,413 shares during the last quarter. Summit Securities Group LLC acquired a new stake in shares of Hims & Hers Health in the fourth quarter worth approximately $38,000. UMB Bank n.a. increased its position in shares of Hims & Hers Health by 247.5% during the first quarter. UMB Bank n.a. now owns 1,310 shares of the company's stock worth $39,000 after purchasing an additional 933 shares in the last quarter. Finally, Fifth Third Bancorp raised its stake in Hims & Hers Health by 165.4% in the 1st quarter. Fifth Third Bancorp now owns 1,542 shares of the company's stock valued at $46,000 after purchasing an additional 961 shares during the last quarter. Institutional investors and hedge funds own 63.52% of the company's stock.

Hims & Hers Health Price Performance

HIMS traded up $3.15 during trading hours on Friday, reaching $49.43. The company's stock had a trading volume of 83,155,526 shares, compared to its average volume of 23,099,623. The stock has a market cap of $11.06 billion, a PE ratio of 71.63, a P/E/G ratio of 1.56 and a beta of 2.09. Hims & Hers Health, Inc. has a fifty-two week low of $13.47 and a fifty-two week high of $72.98. The business's 50-day moving average is $49.65 and its 200-day moving average is $39.46.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $0.20 EPS for the quarter, beating analysts' consensus estimates of $0.12 by $0.08. The company had revenue of $586.01 million for the quarter, compared to the consensus estimate of $535.21 million. Hims & Hers Health had a return on equity of 22.75% and a net margin of 9.24%. The company's revenue for the quarter was up 110.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.05 earnings per share. Analysts expect that Hims & Hers Health, Inc. will post 0.29 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on HIMS shares. Morgan Stanley reaffirmed an "equal weight" rating and set a $40.00 target price on shares of Hims & Hers Health in a research note on Wednesday, June 11th. Bank of America raised their price target on shares of Hims & Hers Health from $22.00 to $26.00 and gave the stock an "underperform" rating in a research note on Tuesday, April 29th. UBS Group set a $30.00 price objective on shares of Hims & Hers Health in a research note on Monday. TD Cowen downgraded shares of Hims & Hers Health from a "buy" rating to a "hold" rating and cut their price objective for the company from $44.00 to $30.00 in a report on Tuesday, April 29th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Hims & Hers Health in a research note on Monday. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Hims & Hers Health currently has an average rating of "Hold" and a consensus target price of $38.31.

Insider Buying and Selling at Hims & Hers Health

In related news, insider Michael Chi sold 17,102 shares of the business's stock in a transaction on Tuesday, June 17th. The stock was sold at an average price of $59.75, for a total value of $1,021,844.50. Following the sale, the insider now owns 278,654 shares in the company, valued at approximately $16,649,576.50. The trade was a 5.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Oluyemi Okupe sold 11,581 shares of the stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $60.22, for a total value of $697,407.82. Following the transaction, the chief financial officer now directly owns 113,816 shares in the company, valued at approximately $6,853,999.52. The trade was a 9.24% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 706,454 shares of company stock valued at $35,220,112 over the last 90 days. 13.71% of the stock is owned by insiders.

Hims & Hers Health Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.